Rational screening of peroxisome proliferator-activated receptor-γ agonists from natural products: potential therapeutics for heart failure

Principal component analysis: a review and recent developments

(2016) Ian T. Jolliffe et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES

Pharmacophore modeling improves virtual screening for novel peroxisome proliferator-activated receptor-gamma ligands

(2015) Stephanie N. Lewis et al.   JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN

High-throughput screening against $$\sim $$ ∼ 6.1 million structurally diverse, lead-like compounds to discover novel ROCK inhibitors for cerebral injury recovery

(2015) Haoling Gong et al.   MOLECULAR DIVERSITY

The re-emergence of natural products for drug discovery in the genomics era

(2015) Alan L. Harvey et al.   NATURE REVIEWS DRUG DISCOVERY

Target enhanced 2D similarity search by using explicit biological activity annotations and profiles

(2015) Xiang Yu et al.   Journal of Cheminformatics

State of the art paper Heart failure in the diabetic population – pathophysiology, diagnosis and management

(2014) Jacek Kasznicki et al.   Archives of Medical Science

Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review

(2014) Limei Wang et al.   BIOCHEMICAL PHARMACOLOGY

PPAR Gamma Expression Levels during Development of Heart Failure in Patients with Coronary Artery Disease after Coronary Artery Bypass-Grafting

(2014) Izabela Wojtkowska et al.   PPAR Research

Use of Clinically Available PPAR Agonists for Heart Failure; Do the Risks Outweigh the Potential Benefits?

(2012) Satyam Sarma   Current Molecular Pharmacology

Automated Docking Screens: A Feasibility Study

(2009) John J. Irwin et al.   JOURNAL OF MEDICINAL CHEMISTRY

Antidiabetic and Hypolipidemic Effects of a Novel Dual Peroxisome Proliferator-Activated Receptor (PPAR) α/γ Agonist, E3030, in db/db Mice and Beagle Dogs

(2008) Shunji Kasai et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES